Targeting CRTC2 reverses STK11 mutant NSCLC tumor resistance to immunotherapy - Dimitri Robay; Ole Ackermann; Laurent Laborde; Xingyi Shi; Federico Oreglia; Ramona Stump; Sabina Ciaghi; Giorgio G. Galli; Laura Holzer; Lorraine Villemin; Joel Wagner; Jincheng Wu; et al. (Proceedings of the National Academy of Sciences, 2026)